BRTX
Price
$1.61
Change
-$0.06 (-3.59%)
Updated
Jun 27 closing price
Capitalization
12.08M
50 days until earnings call
INRLF
Price
$3.10
Change
-$0.15 (-4.62%)
Updated
Jun 10 closing price
Capitalization
477.59M
Interact to see
Advertisement

BRTX vs INRLF

Header iconBRTX vs INRLF Comparison
Open Charts BRTX vs INRLFBanner chart's image
BioRestorative Therapies
Price$1.61
Change-$0.06 (-3.59%)
Volume$36.82K
Capitalization12.08M
Valneva SE
Price$3.10
Change-$0.15 (-4.62%)
Volume$100
Capitalization477.59M
BRTX vs INRLF Comparison Chart in %
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. INRLF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Buy and INRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BRTX: $1.61 vs. INRLF: $3.10)
Brand notoriety: BRTX and INRLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 29% vs. INRLF: 6%
Market capitalization -- BRTX: $12.08M vs. INRLF: $477.59M
BRTX [@Biotechnology] is valued at $12.08M. INRLF’s [@Biotechnology] market capitalization is $477.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 0 FA rating(s) are green whileINRLF’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 0 green, 5 red.
  • INRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRTX and INRLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 3 TA indicator(s) are bullish while INRLF’s TA Score has 2 bullish TA indicator(s).

  • BRTX’s TA Score: 3 bullish, 7 bearish.
  • INRLF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, INRLF is a better buy in the short-term than BRTX.

Price Growth

BRTX (@Biotechnology) experienced а +1.90% price change this week, while INRLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BRTX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($478M) has a higher market cap than BRTX($12.1M). INRLF YTD gains are higher at: 48.230 vs. BRTX (12.587). BRTX has higher annual earnings (EBITDA): -12.06M vs. INRLF (-55.24M). INRLF has more cash in the bank: 153M vs. BRTX (9.11M). BRTX has less debt than INRLF: BRTX (42.4K) vs INRLF (211M). INRLF has higher revenues than BRTX: INRLF (186M) vs BRTX (391K).
BRTXINRLFBRTX / INRLF
Capitalization12.1M478M3%
EBITDA-12.06M-55.24M22%
Gain YTD12.58748.23026%
P/E RatioN/AN/A-
Revenue391K186M0%
Total Cash9.11M153M6%
Total Debt42.4K211M0%
FUNDAMENTALS RATINGS
BRTX vs INRLF: Fundamental Ratings
BRTX
INRLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6254
P/E GROWTH RATING
1..100
10078
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRTX's Valuation (36) in the null industry is in the same range as INRLF (50). This means that BRTX’s stock grew similarly to INRLF’s over the last 12 months.

BRTX's Profit vs Risk Rating (98) in the null industry is in the same range as INRLF (100). This means that BRTX’s stock grew similarly to INRLF’s over the last 12 months.

INRLF's SMR Rating (97) in the null industry is in the same range as BRTX (98). This means that INRLF’s stock grew similarly to BRTX’s over the last 12 months.

INRLF's Price Growth Rating (54) in the null industry is in the same range as BRTX (62). This means that INRLF’s stock grew similarly to BRTX’s over the last 12 months.

INRLF's P/E Growth Rating (78) in the null industry is in the same range as BRTX (100). This means that INRLF’s stock grew similarly to BRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRTXINRLF
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
41%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
65%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 19 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSM164.222.29
+1.41%
Williams-Sonoma
GYRE7.420.04
+0.54%
Gyre Therapeutics
MTSR28.59-0.12
-0.42%
Metsera Inc
PHGE0.44-0.01
-2.22%
BiomX Inc
ALAR12.85-0.54
-4.03%
Alarum Technologies Ltd

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with LGVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-3.59%
LGVN - BRTX
42%
Loosely correlated
+1.54%
SBMFF - BRTX
35%
Loosely correlated
N/A
RNA - BRTX
33%
Poorly correlated
-2.68%
ORIC - BRTX
30%
Poorly correlated
-1.81%
NUVL - BRTX
30%
Poorly correlated
+0.68%
More

INRLF and

Correlation & Price change

A.I.dvisor tells us that INRLF and BRTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INRLF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
BRTX - INRLF
27%
Poorly correlated
-3.59%
SBMFF - INRLF
24%
Poorly correlated
N/A
ONCY - INRLF
21%
Poorly correlated
+4.25%
XFOR - INRLF
20%
Poorly correlated
-8.50%
HSTC - INRLF
4%
Poorly correlated
N/A
More